However, quality of life considerations remain paramount, and alternative therapeutic options should be discussed if side effects significantly impair daily functioning despite comprehensive management strategies
It has been reported that the intestinal environment (bacteria and viruses) changes even before the onset of type 1 diabetes mellitus (T1DM) and that there are bacteria that inhibit the onset of T1DM 3,4,5
Drug News Perspect 16:413422 Nauck MA, Meier JJ (2005) Glucagon-like peptide 1 (GLP-1) and its derivatives in the treatment of diabetes
Thought to be diet related advise people either to take oral cyanocobalamin tablets 50150 micrograms daily between meals, or have a twice-yearly hydroxocobalamin 1 mg injection
In addition to nausea, patients taking GLP-1 medications may experience diarrhea, vomiting, constipation and stomach pain
D.SeleV.et al (2017)